55 results
8-K
EX-10.2
IMCR
Immunocore Holdings plc
28 May 24
Entry into a Material Definitive Agreement
4:17pm
the expenses of any regular or special audit and cold comfort letters required by or incident to such performance), (v) any reasonable fees and disbursements
10-Q
2024 Q1
EX-31.1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors
10-Q
2024 Q1
EX-31.2
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
for further accounting, audit, legal, regulatory and consulting services, and pay costs associated with maintaining compliance with Nasdaq listing rules … selling, distribution, commercial, accounting, audit, legal, regulatory, compliance, director and officer insurance costs as well as investor
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
GENERAL MEETING OF SHAREHOLDERS
RESOLUTION 7 AUTHORIZATION FOR THE AUDIT COMMITTEE TO DETERMINE THE U.K. STATUTORY AUDITORS’ REMUNERATION … meeting of shareholders
FOR
To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the year ending December 31
PRE 14A
32jvlnw j3v7pb
2 Apr 24
Preliminary proxy
4:45pm
10-K
hbj9bs0u
28 Feb 24
Annual report
7:33am
10-K
EX-31.1
wyz5sx5otefyxszw
28 Feb 24
Annual report
7:33am
10-K
EX-31.2
iv833s59x
28 Feb 24
Annual report
7:33am
8-K
necoltc1 tk
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
6-K
EX-99.2
p755w
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.2
em862q8zr5u9r 9ce
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
x95mj
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.1
7ztn7vgw5vo0zjthych
18 Apr 23
Current report (foreign)
4:13pm
6-K
EX-99.4
f3wgkd w4
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.2
j5obx7wl97p3ns
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
7tmehhyhgp4bfqsf
30 Sep 22
Prospectus with selling stockholder info
4:15pm
424B5
hkeqcr
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
EX-99.2
rp9hdrenr8 nkjtehj
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.3
4ae12vixyusd9xjq8
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am